Login / Signup

Economic Evaluation of Multiple-Pharmacogenes Testing for the Prevention of Adverse Drug Reactions in People Living with HIV.

Saowalak TurongkaraveeNaiyana PraditsitthikornThundon NgamprasertchaiJiraphun JittikoonSurakameth MahasirimongkolChonlaphat SukasemWanvisa UdomsinprasertOlivia WuUsa Chaikledkaew
Published in: ClinicoEconomics and outcomes research : CEOR (2022)
Single and multiple-PGx testing might be cost-effective options for reducing the incidence of drug-induced serious ADRs in people living with HIV.
Keyphrases
  • adverse drug
  • drug induced
  • liver injury
  • electronic health record
  • risk factors